Towa Pharmaceutical Co (JP:4553) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts and uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Towa Pharmaceutical Co. reported a strong financial performance for the first half of 2024, with a 14.9% increase in net sales and a significant 50.1% rise in operating profit compared to the previous year. However, profit attributable to owners of the parent decreased by 5.7%, indicating some financial challenges despite overall growth.
For further insights into JP:4553 stock, check out TipRanks’ Stock Analysis page.
